Recall Enforment Report D-0264-2021

Recall Details

Multi event Drug Recall Enforcement Report Class II voluntary initiated by Ascend Laboratories LLC, originally initiated on 01-22-2021 for the product Cephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68 The product was recalled due to cgmp deviations: individual unidentified impurities results of the product was found at higher side of the specification limit.. The product was distributed nationwide and the recall is currently terminated.

Recall Enforcement Reports

Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status
D-0264-202101-22-202102-24-2021Class II23,436 200 mL bottlesCephalexin for Oral Suspension, USP 250 mg per 5 mL 200 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-68CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.Terminated
D-0263-202101-22-202102-24-2021Class II14,205 100 mL bottlesCephalexin for Oral Suspension, USP 250 mg per 5 mL, 100 ml (when mixed) Rx Only, Manufactured by: Alkem Laboratories, Ltd, Mumbai -400 013 INDIA Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-545-88CGMP Deviations: Individual Unidentified impurities results of the product was found at higher side of the specification limit.Terminated

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
67877-544Cephalexin CephalexinFor SuspensionOralAscend Laboratories, LlcHuman Prescription Drug
67877-545Cephalexin CephalexinFor SuspensionOralAscend Laboratories, LlcHuman Prescription Drug